Holen Sie sich die Stockscreener-App
6.11
5.12%
-0.33
Handel nachbörslich:
6.11
Finanzdaten der Design Therapeutics Inc-Aktie (DSGN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
5.64%
21.57
|
20.42 | 16.69 | 16.25 | 15.04 |
| Operating Income/Loss |
5.64%
-21.57
|
-20.42 | -16.69 | -16.25 | -15.04 |
| Income/Loss From Continuing Operations Before Tax |
7.72%
-19.08
|
-17.71 | -13.65 | -13.04 | -11.79 |
| Income/Loss From Continuing Operations After Tax |
7.72%
-19.08
|
-17.71 | -13.65 | -13.04 | -11.79 |
|
Net Income/Loss
|
7.72%
-19.08
|
-17.71 | -13.65 | -13.04 | -11.79 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.18%
56.86
|
56.76 | 0.0318 | 56.62 | 56.56 |
| Diluted Average Shares |
0.18%
56.86
|
56.76 | 0.0318 | 56.62 | 56.56 |
| Basic Earnings Per Share |
9.68%
-0.34
|
-0.31 | -0.24 | -0.23 | -0.21 |
| Diluted Earnings Per Share |
9.68%
-0.34
|
-0.31 | -0.24 | -0.23 | -0.21 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):